| 1 |
35579824 | Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model. | 2022 May 17 |
1 |
| 2 |
34503953 | Complex Cytochrome P450 Kinetics Due to Multisubstrate Binding and Sequential Metabolism. Part 2. Modeling of Experimental Data. | 2021 Dec |
2 |
| 3 |
22651985 | Toxicity of clopidogrel and ticlopidine on human myeloid progenitor cells: importance of metabolites. | 2012 Sep 28 |
1 |
| 4 |
21832258 | Luciferin IPA-based higher throughput human hepatocyte screening assays for CYP3A4 inhibition and induction. | 2011 Sep |
1 |
| 5 |
18474675 | Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine) metabolites in human liver microsomes. | 2008 Aug |
1 |
| 6 |
16855053 | Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4. | 2006 Oct |
1 |
| 7 |
10759690 | In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. | 2000 Apr |
1 |
| 8 |
10233213 | Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism. | 1999 Apr |
1 |